Health
A molecular trap against COVID-19 – Science Magazine
The cell surface peptidase angiotensin-converting enzyme 2 (ACE2) is the primary receptor for the spike (S) fusion protein that facilitates cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Numerous studies are evaluating therapeutic…
The cell surface peptidase angiotensin-converting enzyme 2 (ACE2) is the primary receptor for the spike (S) fusion protein that facilitates cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Numerous studies are evaluating therapeutic and preventive treatments that block S protein interactions with ACE2 molecules that are expressed on host cells. For example, the ACE2 binding site can be occluded by monoclonal antibodies, several of which are rapidly advancing in clinica…
-
Noosa News23 hours agoWhy Brisbane needs to (re)embrace Los Angeles
-
General23 hours agoAustralia retains Chappell-Hadlee Trophy after rain washes out second T20I against New Zealand
-
General22 hours agoUK names Sarah Mullally as first female Archbishop of Canterbury to lead Church of England
-
General22 hours agoSussan Ley responds to Andrew Hastie’s Shadow Cabinet resignation